📍 RareDiseaseDay is on February 28. Watch this video to understand a patient's journey with pustular psoriasis. raredisease MedEd LightUpForRare 🖥️ Earn credit by learning more about rare diseases:
Served as an advisor or consultant for: Intrabio LtdHas disclosed the following relevant financial relationships:Served as a speaker or a member of a speakers bureau for: Amgen; Alexion; Ultragenyx
Received grants for clinical research from: Amgen; Alexion; Ascendis; Chugai; Radius; Takeda; UltragenyxServed as an advisor or consultant for: Abbvie; Aria Pharmaceuticals, Inc.; AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb; Chiesi; CSL Behring, DevPro, GlaxoSmithKline; IQVIA; Novartis; Polarean; ProterixBio, Inc.
Served as a speaker or a member of a speakers bureau for: AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; United Therapeutics Received grants for clinical research from: AstraZeneca; Bayer; Biogen; Chiesi; Gilead; GlaxoSmithKline; Merck; Nitto BioPharma; Patara/Respivant; Regeneron Pharmaceuticals; Roche; SanofiHas disclosed the following relevant financial relationships:Received grants for clinical research from: Greenwich Biosciences; Encoded; StokeServed as an advisor or consultant for: Bayer; Biotest; Chugai; CSL Behring; Novo Nordisk; Octapharma; Pfizer; Roche; SOBI;...
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease - Nature MedicineA novel multi-omics workflow, combining gut microbiome metagenomics, metatranscriptomics and metabolomics, enabled the identification of the microbial pathways responsible for the degradation of the immunomodulatory drug 5-ASA in the gut of patients with inflammatory bowel disease.
Lire la suite »
Local Organizations Joining Together to Find Ways to Interrupt the Pathways to Mass ViolenceIn the wake of recent mass shootings, a group of North Texas organizations is working to find pathways to interrupt mass violence.
Lire la suite »
Houston doctor discovers way to treat pancreatic cancer during clinical trialA targeted approach to pancreatic cancer could save lives and spare damage to surrounding tissue.
Lire la suite »
Nasal Covid vaccine shows promise in early clinical trialA nasal vaccine was found to reduce the risk of symptomatic Covid infections by 86% for three months in people who received it as a booster dose, according to a preliminary clinical trial. Researchers also recorded fewer side effects with the new vaccine.
Lire la suite »
Changes in Alzheimer's Pathology Don't Match Clinical TrendsWhile recent studies have suggested a decrease in the incidence of clinical dementia in the US, there does not seem to have been a corresponding reduction in neurodegenerative pathologies, a new study shows. NeuroTwitter
Lire la suite »
AI-Based Imaging Technology May Predict Lung Cancer OutcomesAdvanced imaging technology that uses AI can potentially predict which patients with lungcancer are likely to experience cancer progression after surgery, according to new data. OncTwitter
Lire la suite »